UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052231
Receipt number R000059617
Scientific Title An fMRI study of inferring medical diagnoses in expert clinicians
Date of disclosure of the study information 2023/09/18
Last modified on 2023/09/17 18:58:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An fMRI study of inferring medical diagnoses in expert clinicians

Acronym

An fMRI study of inferring medical diagnoses in expert clinicians

Scientific Title

An fMRI study of inferring medical diagnoses in expert clinicians

Scientific Title:Acronym

An fMRI study of inferring medical diagnoses in expert clinicians

Region

Japan


Condition

Condition

Healthy subjects

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the neural substrates of inferring medical diagnoses in expert clinicians

Basic objectives2

Others

Basic objectives -Others

To investigate the neural mechanisms of inferring medical diagnoses

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

parameters of fMRI tasks

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

22 years-old <=

Age-upper limit

50 years-old >

Gender

Male

Key inclusion criteria

Expert clinicians
Medical university students in Japan (5th or 6th grade)
Capability of informed consent

Key exclusion criteria

Subjects who have psychiatric disorders
Subjects who are contraindicated for the use of MRI
Claustrophobia
Subjects who use psychotropic medications and hypnotics.
Subjects who are judged as unsuitable for participation in this study

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Junya
Middle name
Last name Fujino

Organization

Tokyo Medical and Dental University

Division name

Department of Psychiatry and Behavioral Sciences

Zip code

113-0034

Address

1-5-45 Yushima, Bunkyo-ku, Tokyo

TEL

03-3813-6111

Email

jf15psyc@tmd.ac.jp


Public contact

Name of contact person

1st name Takao Kanai
Middle name
Last name Junya Fujino

Organization

Tokyo Medical and Dental University

Division name

Department of Psychiatry and Behavioral Sciences

Zip code

113-0034

Address

1-5-45 Yushima, Bunkyo-ku, Tokyo

TEL

03-3813-6111

Homepage URL


Email

jf15psyc@tmd.ac.jp


Sponsor or person

Institute

Tokyo Medical and Dental University

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional review board of Tokyo Medical and Dental University

Address

1-5-45 Yushima, Bunkyo-ku, Tokyo

Tel

03-3813-6111

Email

syomu1.adm@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 09 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 01 Month 12 Day

Date of IRB

2023 Year 01 Month 12 Day

Anticipated trial start date

2023 Year 09 Month 20 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

An fMRI study


Management information

Registered date

2023 Year 09 Month 17 Day

Last modified on

2023 Year 09 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059617